Mutual Fund Ownership
Ownership as on: Tue, 16 Apr, 2024

ITI Pharma and Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)2.16
% of AUM1.35%

Quant ELSS Tax Saver Growth

5/5
Equity
Amount Invested (Cr.)21.95
% of AUM0.26%

Edelweiss Nifty Smallcap 250 Index Fund Regular Growth

NA
Index Funds
Amount Invested (Cr.)0.08
% of AUM0.19%

Motilal Oswal Nifty Smallcap 250 Index Fund Regular Growth

NA
Index Funds
Amount Invested (Cr.)1.12
% of AUM0.19%

HDFC Nifty Smallcap 250 Index Fund Regular Growth

NA
Index Funds
Amount Invested (Cr.)0.26
% of AUM0.19%

FAQs about Sun Pharma Advanced Research Com share price

Sun Pharma Advanced Research Com is trading at 369.65 as on Tue Apr 16 2024 09:58:45. This is -5.00% lower as compared to its previous closing price of 389.10.

The market capitalization of Sun Pharma Advanced Research Com is 11995.94 Cr as on Tue Apr 16 2024 09:58:45.

The average broker rating on Sun Pharma Advanced Research Com is Buy. The breakup of analyst rating is given below -

  • 0 analysts have given a strong buy rating
  • 1 analysts have given a buy rating
  • 0 analysts have given a hold rating
  • 0 analysts have given a sell rating
  • 0 analysts have given a strong sell rating

The 52 wk high for Sun Pharma Advanced Research Com is 474.00 whereas the 52 wk low is 178.10

Sun Pharma Advanced Research Com can be analyzed on the following key metrics -

  • TTM P/E: -
  • Sector P/E: 27.85
  • Dividend Yield: 0.00%
  • D/E ratio: -

Sun Pharma Advanced Research Com reported a net profit of -222.58 Cr in 2023.

Recommended For You
Trending Stocks
3,647.05+45.50(1.26%)
2,220.90+26.30(1.20%)
1,509.40+14.45(0.97%)
1,414.75-53.55 (-3.65%)
1,490.75-48.05 (-3.12%)